These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18752358)

  • 1. [Colorectal cancer screening with fecal occult blood testing].
    Díaz Tasende J; Marín Gabriel JC
    Rev Esp Enferm Dig; 2008 Jun; 100(6):315-9. PubMed ID: 18752358
    [No Abstract]   [Full Text] [Related]  

  • 2. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. American College of Physicians.
    Ann Intern Med; 1997 May; 126(10):808-10. PubMed ID: 9148657
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
    Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening with fecal occult blood testing (FOBT): an international perspective.
    Achkar E; Moayyedi P
    Am J Gastroenterol; 2006 Feb; 101(2):212. PubMed ID: 16454818
    [No Abstract]   [Full Text] [Related]  

  • 6. Fecal occult blood testing options.
    Lastella VP
    Gastroenterology; 2006 Jan; 130(1):285; author reply 285. PubMed ID: 16401498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fecal occult blood testing for colorectal cancer ].
    Mohr E
    Rev Med Liege; 2003 May; 58(5):327-30. PubMed ID: 12940125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of a single fecal occult blood test in screening for colorectal cancer.
    Kane RC
    Ann Intern Med; 2005 Aug; 143(3):235. PubMed ID: 16061928
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the effectiveness of fecal occult blood screening for colorectal cancer.
    Bond JH
    J Natl Cancer Inst; 1999 Oct; 91(19):1602-3. PubMed ID: 10511580
    [No Abstract]   [Full Text] [Related]  

  • 11. Population screening for colorectal carcinoma with fecal-occult blood testing: are we sufficiently informed?
    Agrez MV; Coory M; Cockburn J
    Cancer; 1998 May; 82(10):1803-7. PubMed ID: 9587111
    [No Abstract]   [Full Text] [Related]  

  • 12. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting.
    Janda M; Hughes KL; Auster JF; Leggett BA; Newman BM
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1661-7. PubMed ID: 20880176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office-based testing for fecal occult blood.
    Jackson C; Craig R
    Ann Intern Med; 2005 Aug; 143(3):235-6; author reply 236. PubMed ID: 16061925
    [No Abstract]   [Full Text] [Related]  

  • 14. Office-based testing for fecal occult blood.
    Hoffer EP
    Ann Intern Med; 2005 Aug; 143(3):235; author reply 236. PubMed ID: 16061926
    [No Abstract]   [Full Text] [Related]  

  • 15. Office-based testing for fecal occult blood.
    Wolff ML
    Ann Intern Med; 2005 Aug; 143(3):235; author reply 236. PubMed ID: 16061927
    [No Abstract]   [Full Text] [Related]  

  • 16. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
    Olynyk JK; Platell CF; Collett JA
    J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
    Ransohoff DF; Lang CA
    Ann Intern Med; 1997 May; 126(10):811-22. PubMed ID: 9148658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.